Ensign Peak Advisors’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$164K Hold
6,606
﹤0.01% 1405
2025
Q4
$168K Sell
6,606
-15,700
-70% -$350K ﹤0.01% 1387
2025
Q3
$360K Sell
22,306
-6,100
-21% -$98.8K ﹤0.01% 1521
2025
Q2
$454K Hold
28,406
﹤0.01% 1582
2025
Q1
$485K Buy
28,406
+8,700
+44% +$182K ﹤0.01% 1562
2024
Q4
$488K Sell
19,706
-138,915
-88% -$3.94M ﹤0.01% 1602
2024
Q3
$4.52M Sell
158,621
-45,600
-22% -$1.34M 0.01% 654
2024
Q2
$5.39M Buy
204,221
+37,165
+22% +$1.06M 0.01% 604
2024
Q1
$5.4M Sell
167,056
-994
-0.6% -$36.3K 0.01% 615
2023
Q4
$7.08M Buy
168,050
+20,700
+14% +$762K 0.01% 536
2023
Q3
$5.66M Buy
+147,350
New +$3.33M 0.01% 532
2022
Q4
Sell
-6,350
Closed -$35K 1985
2022
Q3
$35K Buy
6,350
+2,670
+73% +$13.1K ﹤0.01% 2264
2022
Q2
$14K Hold
3,680
﹤0.01% 2140
2022
Q1
$20K Hold
3,680
﹤0.01% 2180
2021
Q4
$31K Buy
+3,680
New +$30.4K ﹤0.01% 2166

Other funds holding IMVT